China National Medicines Corp Ltd (600511) — Cash Flow Reinvestment Rate

Latest as of June 2025: 0.11x

China National Medicines Corp Ltd (600511) has a Cash Flow Reinvestment Rate of 0.11x as of June 2025, reinvesting CN¥42.55 Million (capex CN¥13.23 Million plus investments CN¥29.33 Million) from operating cash flow of CN¥382.74 Million. See China National Medicines Corp Ltd (600511) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.11x
(Capex + Investments) / Operating CF

Total Reinvested

CN¥42.55 Million
Capex + Investments

Operating Cash Flow

CN¥382.74 Million
CNY

Capital Expenditures

CN¥13.23 Million
CNY

China National Medicines Corp Ltd Cash Flow Reinvestment Rate (2002–2024)

Historical reinvestment intensity for China National Medicines Corp Ltd across 22 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of China National Medicines Corp Ltd.

Annual Cash Flow Reinvestment Rate for China National Medicines Corp Ltd (2002–2024)

Year-by-year capital reinvestment analysis for China National Medicines Corp Ltd. See financial agility of China National Medicines Corp Ltd to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (CNY) Operating CF Capex YoY Change
2024 0.11x CN¥177.45 Million CN¥1.66 Billion CN¥130.77 Million ▲ +6.3%
2023 0.10x CN¥274.44 Million CN¥2.73 Billion CN¥145.12 Million ▼ -14.5%
2022 0.12x CN¥282.10 Million CN¥2.40 Billion CN¥129.78 Million ▲ +108.0%
2021 0.06x CN¥110.82 Million CN¥1.96 Billion CN¥95.07 Million ▲ +2.5%
2020 0.06x CN¥71.92 Million CN¥1.30 Billion CN¥69.05 Million ▲ +13.3%
2019 0.05x CN¥86.62 Million CN¥1.78 Billion CN¥85.72 Million ▼ -75.2%
2018 0.20x CN¥192.66 Million CN¥981.65 Million CN¥132.46 Million ▲ +79.3%
2017 0.11x CN¥117.63 Million CN¥1.07 Billion CN¥73.25 Million ▼ -20.3%
2016 0.14x CN¥81.25 Million CN¥591.25 Million CN¥39.88 Million ▼ -11.8%
2015 0.16x CN¥68.62 Million CN¥440.29 Million CN¥68.47 Million ▼ -77.0%
2014 0.68x CN¥148.22 Million CN¥218.94 Million CN¥148.22 Million ▲ +3.3%
2013 0.66x CN¥121.66 Million CN¥185.56 Million CN¥121.66 Million ▼ -28.2%
2012 0.91x CN¥169.65 Million CN¥185.87 Million CN¥169.65 Million ▲ +1105.7%
2010 0.08x CN¥24.09 Million CN¥318.21 Million CN¥24.09 Million ▼ -13.5%
2009 0.09x CN¥22.33 Million CN¥255.18 Million CN¥22.33 Million ▲ +17.2%
2008 0.07x CN¥16.21 Million CN¥217.10 Million CN¥16.21 Million ▼ -31.1%
2007 0.11x CN¥8.61 Million CN¥79.48 Million CN¥8.61 Million ▼ -44.7%
2006 0.20x CN¥23.81 Million CN¥121.50 Million CN¥23.81 Million ▼ -56.2%
2005 0.45x CN¥41.24 Million CN¥92.20 Million CN¥41.24 Million ▼ -74.7%
2004 1.77x CN¥87.08 Million CN¥49.18 Million CN¥87.08 Million ▼ -99.0%
2003 172.79x CN¥90.92 Million CN¥526.15K CN¥90.92 Million ▲ +18401.7%
2002 0.93x CN¥14.19 Million CN¥15.19 Million CN¥14.19 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow